Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors
This study is ongoing, but not recruiting participants.
Sponsors and Collaborators: University of Copenhagen
The Danish Research Agency
Hjerteforeningen
Techinical University of Denmark
Information provided by: University of Copenhagen
ClinicalTrials.gov Identifier: NCT00266292
  Purpose

The purpose of this study is to investigate the effects of long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA) on immune function and cardiovascular disease risk


Condition Intervention
Cardiovascular Heart Disease
Metabolic Syndrome
Behavioral: Fish oil (Bio-Marine, Pharma Nord)
Behavioral: n-6 PUFA intake (Margarine+sunflower oil vs. butter product+rapeseed oil)

MedlinePlus related topics: Heart Diseases
Drug Information available for: Fish oil
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Factorial Assignment, Efficacy Study

Further study details as provided by University of Copenhagen:

Primary Outcome Measures:
  • Fatty acid composition of PMBC - before and after 2 mo of interventions and after 2 mo of follow-up
  • Ex vivo cytokine production (e.g. IL-6, TNF-α, IL-10, and interferon-γ) in whole blood and PBMC cultures after 24 h of stimulation - before and after interventions and after follow up
  • Plasma CRP, IL-6 & fibrinogen - before, after and follow-up
  • Plasma lipid profile: TAG, cholesterol, LDL & HDL - before, after and follow-up
  • Blood pressure - before, after and follow-up

Secondary Outcome Measures:
  • Anthropometric measures - before, after & follow-up
  • Ex vivo cytokine production in isolated monocytes - after intervention only
  • Endothelial function (PWV and/or arterial compliance) - before & after
  • Superoxide production in full blood samples - before & after
  • Plasma insulin/glucose - before, after and follow-up
  • And if necessary funding is obtained:
  • Plasma markers of endothelial function (e.g. VCAM-1, ICAM-1, Matrix metallo proteinases, E- & P-selectin, nitrite and endothelin-1) - before and after
  • Plasma CD40L - before, after and follow-up
  • RBC fatty acid composition - before, after and follow-up
  • Coagulation factors (e.g. PAI, tPA, factor VII) - before, after and follow-up
  • Folate/homocysteine - before. after and follow-up
  • Lipoprotein(a) - before, after and follow-up

Estimated Enrollment: 60
Study Start Date: September 2005
Estimated Study Completion Date: April 2006
Detailed Description:

In a controlled, double-blinded human intervention study the effects of fish oil versus control (olive oil) and of a high versus low consumption of n-6 polyunsaturated fatty acids are investigated. Sixty-seventy healthy men will be randomized to oil capsules and to substitute their dietary fats with one of two types of oil and butter-product that we provide. Outcome variables are ex vivo cytokine production in full blood and isolated immune cells after 24 h of stimulation with bacteria or bacterial components, blood pressure and arterial function, plasma concentrations of cholesterol, triacylglycerol, C-reactive protein and a number of other markers of endothelial function and cardiovascular risk.

The hypotheses are that both increased intake of n-3 polyunsaturated fatty acids (from fish oil) and a low consumption of n-6 polyunsaturated fatty acids increase incorporation of docosahexanoic acid in immune cell membranes and that this decreases the inflammatory response and potential and improve overall cardiovascular disease risk.

The mechanistic aspects of this will be further explored by in vitro studies with monocytes cultured in the presence of varying amounts of polyunsaturated fatty acids.

  Eligibility

Ages Eligible for Study:   18 Years to 40 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Healthy (no chronic diseases and no regular medications), BMI >18.5 and <27.5 kg/m2, Daily use of fats and home cooking >5 d/wk, Heavy exercise <7 h/wk, Not daily smokers (<5 cigarets/wk)

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00266292

Locations
Denmark
Department of Human Nutrition
Frederiksberg, Denmark, DK-1958
Sponsors and Collaborators
University of Copenhagen
The Danish Research Agency
Hjerteforeningen
Techinical University of Denmark
Investigators
Principal Investigator: Lotte Lauritzen, Ph.D Department of Human Nutrition, Royal Veterinary and Agricultural University, Denmark
  More Information

Study ID Numbers: KF 01 267804, SJVF 23-04-0050, IHE project no. A-304
Study First Received: December 15, 2005
Last Updated: August 8, 2006
ClinicalTrials.gov Identifier: NCT00266292  
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics

Keywords provided by University of Copenhagen:
Fish oil
Polyunsaturated fatty acid
Immune function
Endothelial function
Cardiovascular risk factors

Study placed in the following topic categories:
Heart Diseases

Additional relevant MeSH terms:
Pathologic Processes
Disease
Syndrome
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009